Chest ACCP Career Connection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Holgate, S. T.
Right arrow Articles by Roche, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holgate, S. T.
Right arrow Articles by Roche, W.
(Chest. 1993;103:125S-128S.)
© 1993 American College of Chest Physicians

The T Cell and the Airway's Fibrotic Response in Asthma

Stephen T. Holgate D.Sc.1; Ratko Djukanovicacute M.D.1; Peter H. Howarth M.D.1; Stephen Montefort M.B.B.S.1; and William Roche Ph.D.2

1 The Immunopharmacology Group, Southampton General Hospital, Southampton, UK.
2 The Pathology Department, Southampton General Hospital, Southampton, UK.

As T cells appear to play a pivotal role in initiating allergic airway inflammation involving mast cells and eosinophils, the epithelium appears to be a major target for the response. With epithelial disruption, myofibroblast proliferation provides a mechanism for the laying down interstitial collagens in an attempt to minimize the effects of losing selective permeability. However, like the epithelium in asthma, myoflbroblasts may take on another function—namely, to provide an additional source of cytokines with their capacity to maintain the inflammatory response. From a functional standpoint, subepithelial fibrosis could contribute to the mechanical disability of the airways in asthma as exemplified by steroid-resistant hyperresponsiveness, and if the process spreads deeper into the airway wall to bronchodilator-resistant airways obstruction, a sequel of poorly controlled and severe disease.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the American College of Chest Physicians.